Biosimilars Analytical Strategies

Analysis of Biosimilars and biologics forms to be one of the most important aspect towards the biologics and biosimilar development process. The development pathway of a biosimilar is unlike that of a novel biotherapeutic, requiring earlier extensive analytical characterization. Analysis of biosimilar and biologics takes the longest stretch towards establishing the product in comparison with the original product.

Any manufacturer seeking to develop and market a biopharmaceutical product requires comprehensive physicochemical structural characterization of the (glyco) protein. For biosimilar products, this task is magnified and forms the basis for further comparability. 

  • Biosimilar Bioanalytical methods
  • Biosimilar Formulation
  • Bioassay for comparability and potency testing
  • Biosimilar GMP protein analysis
  • Biosimilar LC/MS analysis for discovery, preclinical, and clinical programs
  • Biosimilar Electrophoresis
  • Biosimilar Multimodal techniques
  • Bioanalytical Challenges

Related Conference of Biosimilars Analytical Strategies

June 06-07, 2018

International Conference & B2B on Pharma Research and Development

Philadelphia, Pennsylvania, USA
June 27-28, 2018

4thInternational Conference on Drug Discovery, Designing Chemistry and Development

Vancouver, British Columbia, Canada
August 20-21, 2018

12th Asian Biologics and Biosimilars Congress

Tokyo, Japan
October 18-20, 2018

18th World Pharma Congress

Warsaw, Poland
November 15-16, 2018

14th International Conference on Generic Drugs and Biosimilars

Frankfurt, Germany
September 18-19, 2018

6 th European Biopharma Congress

Amsterdam, Netherlands

Biosimilars Analytical Strategies Conference Speakers

Recommended Sessions

Related Journals

Are you interested in